AIP: Elevated Future P/E Assumptions Will Likely Constrain Forward Return Potential

Analysts have increased their price target on Arteris by $0.25 to $20.50 as they refresh their assumptions around the discount rate, profit margin, revenue growth and future P/E expectations.

Analyst Commentary

Bullish Takeaways

Bullish analysts view the refreshed assumptions on discount rate, profit margin, revenue growth and future P/E expectations as supportive of a higher valuation ceiling, which is reflected in the recent price target updates.
The $3 increase in the referenced research price target signals confidence that Arteris can better align its execution with those updated financial assumptions, especially around profitability and capital efficiency.
Positive commentary points to a clearer framework for how Arteris could translate revenue growth into earnings power, which underpins the willingness to assign a higher target multiple.
Bullish analysts see the revised target range, including the move to $20.50, as capturing a more complete view of Arteris’s potential earnings profile over time, rather than relying solely on near term results.

Bearish Takeaways

Bearish analysts remain cautious that the refreshed assumptions on margins and growth may be ambitious, which could limit upside if execution or market conditions do not fully support those inputs.
Some caution centers on the reliance on future P/E expectations, which can be sensitive to shifts in sentiment or changes in sector-wide valuation ranges.
There is also a focus on the discount rate assumptions, where any reassessment of risk could pressure valuation and make current price targets harder to justify.
More conservative views highlight that while higher targets have been published, they still depend heavily on Arteris consistently meeting updated financial and operational benchmarks.

What's in the News

Arteris announced a collaboration with MIPS, a GlobalFoundries company, as MIPS selected Arteris FlexGen smart NoC IP and Magillem SoC integration automation software to support scalable SoC platforms for physical AI markets including automotive MCUs, ADAS, robotics, and embedded computing. Arteris system IP is being integrated into MIPS RISC-V based offerings to help customers develop optimized SoCs. (Key Developments)
Renesas licensed and deployed Arteris FlexNoC interconnect IP in its R-Car Gen 5 SoC series and chiplet extensions, using Arteris NoC technology for data movement in AI enabled SoCs that link native NPU and GPU engines with Arm CPU clusters. (Key Developments)
Arteris reported that its technology has shipped in more than 4 billion devices across segments such as automotive and consumer, with recent volumes tied to AI enabled systems and associated variable royalty revenue, in an environment where demand for complex, multi die architectures and interconnect solutions is rising. (Key Developments)
The company issued earnings guidance for the first quarter of 2026, targeting revenue of US$20.5 million to US$21.5 million, and for the full year 2026, targeting revenue of US$89.0 million to US$93.0 million. (Key Developments)
NXP Semiconductors expanded its use of Arteris system IP across its AI enabled silicon solutions for vehicles, industrial systems, and edge consumer applications, integrating FlexNoC and Ncore coherent NoC IP, CodaCache last level cache IP, and Magillem SoC integration software to support data movement and design processes. (Key Developments)

Valuation Changes

Fair Value: the price target has risen slightly from $20.25 to $20.50.
Discount Rate: this has been updated marginally higher from 8.42% to 8.46%, signaling a small adjustment to the risk input.
Revenue Growth: the assumption is essentially unchanged, remaining at 22.86%.
Net Profit Margin: the forecast has risen slightly from 11.39% to 11.45%, indicating a modestly stronger earnings outlook in the model.
Future P/E: the multiple has edged up from 95.17x to 95.97x, reflecting a small increase in the valuation multiple used.

2 views

Key Takeaways

Rising AI adoption and industry shifts toward chiplet architectures are expanding Arteris' market opportunities and supporting sustained revenue growth.
Innovative product launches and stronger customer reliance are boosting competitive advantage, recurring revenues, and margin expansion potential.
Dependence on large customers, rising R&D costs, and evolving industry dynamics threaten revenue stability, profitability, and long-term growth amid ongoing macroeconomic uncertainties.

Catalysts

About Arteris

Provides semiconductor system intellectual property solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East.What are the underlying business or industry changes driving this perspective?

Accelerating adoption of AI and machine learning in enterprise computing and automotive sectors is driving higher demand for Arteris' advanced NoC IP, as evidenced by recent major wins like AMD and Whalechip; this is likely to underpin sustained revenue growth as AI workloads and system complexity proliferate across industries.
The ongoing industry transition to chiplet-based and heterogeneous integration architectures is expanding Arteris' addressable market, with chiplet-related design starts expected to rise from 5% to 30% in coming years; this structural trend supports both higher sales volume and increased average selling prices, benefiting future top-line revenue.
Arteris' launch of innovative products such as FlexGen and Magillem Packaging-recognized with industry awards and integrated into leading chipmaker portfolios-raises the technological moat, improving competitive positioning and enabling potential margin expansion through pricing power.
Increasing reliance by large semiconductor companies on outsourcing specialized system IP, highlighted by growing customer interest and accelerated engagements, suggests expanding recurring revenue streams and enhanced revenue visibility, which may drive more stable and predictable long-term earnings.
Growth in remaining performance obligations (RPO), up 28% year-over-year, signals a solid and expanding contractual revenue base, providing confidence in forward revenue realization and supporting operating leverage as R&D investments start to scale with increased deployment of Arteris' solutions.

Arteris Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Arteris's revenue will grow by 22.9% annually over the next 3 years.
Analysts are not forecasting that Arteris will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Arteris's profit margin will increase from -49.2% to the average US Software industry of 11.5% in 3 years.
If Arteris's profit margin were to converge on the industry average, you could expect earnings to reach $15.0 million (and earnings per share of $0.27) by about May 2029, up from -$34.7 million today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 97.2x on those 2029 earnings, up from -38.4x today. This future PE is greater than the current PE for the US Software industry at 30.3x.
Analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 8.46%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Arteris continues to operate at a net loss and projects a non-GAAP operating loss for the full year 2025 ($10.5 to $15.5 million), indicating ongoing challenges in achieving profitability and potential pressure on earnings and net margins if revenue growth falters or costs escalate.
The high concentration of large whale deals (such as the recent AMD agreement) exposes Arteris to customer concentration risk; if major customers reduce outsourcing, insource NoC IP, or switch providers, future revenues and cash flows could become volatile.
The increasing scale of R&D and field engineering investments, combined with only a gradual ramp in new product adoption, raises the risk that operating costs will outpace revenue growth, which could further suppress margins and delay a path to sustainable earnings.
The expansion of chiplet and heterogeneous integration technologies by mega-customers (like AMD using its own Infinity Fabric for coherent data, and only using Arteris for non-coherent applications) could lead to competitors or major chipmakers developing proprietary NoC solutions, diminishing Arteris' external market and negatively impacting long-term revenue growth.
Macroeconomic uncertainty (including FX fluctuations, global economic conditions, and possible geopolitical headwinds) can impact deal flow, OpEx (as seen recently with unfavorable USD/EUR movements), and delay sales cycles, all of which add risk to revenue predictability and margin expansion over time.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $20.5 for Arteris based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $24.0, and the most bearish reporting a price target of just $16.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $130.9 million, earnings will come to $15.0 million, and it would be trading on a PE ratio of 97.2x, assuming you use a discount rate of 8.5%.
Given the current share price of $28.95, the analyst price target of $20.5 is 41.2% lower. Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Arteris?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Broader Partnerships And AI Adoption Will Shape Future Enterprise Demand